A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

Completed · Phase 4

Conditions studied: HIV Infections, Hepatic Insufficiency

In brief

The objective of this study was to evaluate the steady-state clearance of nevirapine among HIV-1 positive patients with hepatic fibrosis, and to examine whether the degree of hepatic impairment influences clearance.

Key facts

Study ID

NCT00144248

Run by

Boehringer Ingelheim

People needed

51

Starts

2004-06-25

Last updated by the study team

2023-12-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Boehringer Ingelheim Investigational Site — Bakersfield, California, United States
• Boehringer Ingelheim Investigational Site — San Francisco, California, United States
• California Pacific Medical Center — San Francisco, California, United States
• Albany Medical College, MC 142 — Albany, New York, United States
• Boehringer Ingelheim Investigational Site — Providence, Rhode Island, United States
• Hopital de l'Hotel Dieu — Lyon, France
• Hopital Pitie Salpetriere — Paris, France
• Hospital Clinico y Provincial de Barcelona - HIV — Barcelona, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.